product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Human TNF RI/TNFRSF1A Antibody
catalog :
MAB625-100
quantity :
100 ug (also 25 ug, 500 ug)
price :
519 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
16805
reactivity :
human
application :
western blot, ELISA, neutralization, flow cytometry
more info or order :
citations: 28
Reference
Ben Khemis M, Liu D, Pintard C, Song Z, Hurtado Nedelec M, Marie J, et al. TNFα counteracts interleukin-10 anti-inflammatory pathway through the NOX2-Lyn-SHP-1 axis in human monocytes. Redox Biol. 2023;67:102898 pubmed publisher
Menevse A, Ammer L, Vollmann Zwerenz A, Kupczyk M, Lorenz J, Weidner L, et al. TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma. Acta Neuropathol Commun. 2023;11:75 pubmed publisher
Baram T, Oren N, Erlichman N, Meshel T, Ben Baruch A. Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer. Cancers (Basel). 2022;14: pubmed publisher
Rao T, Beggs R, Ankenbauer K, Hwang J, Ma V, Salaita K, et al. ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion. J Biol Chem. 2022;298:101726 pubmed publisher
Zhu W, Qiu Q, Luo H, Zhang F, Wu J, Zhu X, et al. High Glucose Exacerbates TNF-α-Induced Proliferative Inhibition in Human Periodontal Ligament Stem Cells through Upregulation and Activation of TNF Receptor 1. Stem Cells Int. 2020;2020:4910767 pubmed publisher
Ahmad R, Kochumon S, Chandy B, Shenouda S, Koshy M, Hasan A, et al. TNF-α Drives the CCL4 Expression in Human Monocytic Cells: Involvement of the SAPK/JNK and NF-κB Signaling Pathways. Cell Physiol Biochem. 2019;52:908-921 pubmed publisher
Bin L, Li X, Richers B, Streib J, Hu J, Taylor P, et al. Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum. J Allergy Clin Immunol. 2018;141:2085-2093.e1 pubmed publisher
Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed publisher
Steeland S, Puimège L, Vandenbroucke R, Van Hauwermeiren F, Haustraete J, Devoogdt N, et al. Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1. J Biol Chem. 2015;290:4022-37 pubmed publisher
Loosbroock C, Hunter K. Inhibiting TNF-α signaling does not attenuate induction of endotoxin tolerance. J Inflamm Res. 2014;7:159-67 pubmed publisher
Ueda M, Fujisawa T, Ono M, Hara E, Pham H, Nakajima R, et al. A short-term treatment with tumor necrosis factor-alpha enhances stem cell phenotype of human dental pulp cells. Stem Cell Res Ther. 2014;5:31 pubmed publisher
Denoyer A, Godefroy D, Celerier I, Frugier J, Riancho L, Baudouin F, et al. CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation. Mucosal Immunol. 2012;5:702-11 pubmed publisher
Zhao X, Qureshi F, Eastman P, Manning W, Alexander C, Robinson W, et al. Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis. J Immunol Methods. 2012;378:72-80 pubmed publisher
Bastarache J, Sebag S, Grove B, Ware L. Interferon-? and tumor necrosis factor-? act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res. 2011;37:509-17 pubmed publisher
Turner Brannen E, Choi K, Arsenault R, El Gabalawy H, Napper S, Mookherjee N. Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1. J Immunol. 2011;186:7127-35 pubmed publisher
Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova I. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 2010;115:4421-30 pubmed publisher
Hu H, Kwun J, Aizenstein B, Knechtle S. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation. 2009;87:1814-20 pubmed publisher
Emsley H, Smith C, Gavin C, Georgiou R, Vail A, Barberan E, et al. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol. 2007;7:5 pubmed
Lee S, Cherla R, Tesh V. Simultaneous induction of apoptotic and survival signaling pathways in macrophage-like THP-1 cells by Shiga toxin 1. Infect Immun. 2007;75:1291-302 pubmed
Edwards J, Sun S, Locklin R, Shipman C, Adamopoulos I, Athanasou N, et al. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum. 2006;54:1451-62 pubmed
Mozaffarian D, Rimm E, King I, Lawler R, McDonald G, Levy W. trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr. 2004;80:1521-5 pubmed
Ricci Vitiani L, Pedini F, Mollinari C, Condorelli G, Bonci D, Bez A, et al. Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J Exp Med. 2004;200:1257-66 pubmed
Chopin V, Slomianny C, Hondermarck H, Le Bourhis X. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Exp Cell Res. 2004;298:560-73 pubmed
Hawari F, Rouhani F, Cui X, Yu Z, Buckley C, Kaler M, et al. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc Natl Acad Sci U S A. 2004;101:1297-302 pubmed
Copeland S, Siddiqui J, Remick D. Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J Immunol Methods. 2004;284:99-106 pubmed
Gee K, Lim W, Ma W, Nandan D, Diaz Mitoma F, Kozlowski M, et al. Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression. J Immunol. 2002;169:5660-72 pubmed
Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology. 2002;46:76-84 pubmed
Bharucha A, Jorgensen R, Lichtman S, LaRusso N, Lindor K. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis. Am J Gastroenterol. 2000;95:2338-42 pubmed
product information
master code :
MAB625
SKU :
MAB625-100
product name :
Human TNF RI/TNFRSF1A Antibody
unit size :
100 ug (also 25 ug, 500 ug)
description :
The Human TNF RI/TNFRSF1A Antibody from R&D Systems is a mouse monoclonal antibody to TNF RI/TNFRSF1A. This antibody reacts with human. The Human TNF RI/TNFRSF1A Antibody has been validated for the following applications: Neutralization,Antibody Array Development,Array Development,ELISA Development,ELISA Development (Capture),Neutralizing,Flow Cytometry,Western Blot,Functional Assay,ELISA Capture,ELISA Capture (Matched Antibody Pair).
target :
TNF RI/TNFRSF1A
category :
Primary Antibodies
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.
clonality :
Monoclonal
clone :
16805
conjugate :
Unconjugated
host :
Mouse
immunogen :
E. coli -derived recombinant human TNF RI/TNFRSF1A, Extracellular domain
isotype :
IgG1
purity :
Protein A or G purified from ascites
species :
Human
specificity :
Detects human TNF RI/TNFRSF1A in ELISAs and Western blots. In sandwich immunoassays, no significant cross-reactivity or interference with recombinant human (rh) TGF-alpha , hTGF┐▀1, porcine (p) TGF┐▀1, rhTGF┐▀1, pTGF┐▀1.2, pTGF┐▀2, recombinant chicken TGF┐▀3, rhTGF┐▀3, recombinant amphibian TGF┐▀5, rhTNF┐▀, or rhTNF RII is observed.
gene symbol :
TNFRSF1A
endotoxin note :
<0.10 EU per 1 ╡g of the antibody by the LAL method.
top caption :
TNF RI/TNFRSF1A Inhibition of TNF-a-induced Cytotoxicity and Neutralization by Human TNF RI/TNFRSF1A Antibody.
applications :
Antibody Array Development,Array Development,ELISA Development,ELISA Development (Capture),Neutralizing,Flow Cytometry,Western Blot,Neutralization,Functional Assay,ELISA Capture,ELISA Capture (Matched Antibody Pair)
USD :
519 USD
alt names :
CD120a, CD120a antigen, FPF, p55, p55-R, p60, TNFARMGC19588, TNF-R, TNF-R1, TNFR1TBP1, TNFR55, TNF-R55, TNFR60, TNFRI, TNF-RI, TNF-R-I, TNFR-I, TNFRSF1A, tumor necrosis factor binding protein 1, Tumor necrosis factor receptor 1, tumor necrosis factor receptor 1A isoform beta, tumor necrosis factor receptor superfamily member 1A, tumor necrosis factor receptor superfamily, member 1A, tumor necrosis factor receptor type 1, Tumor necrosis factor receptor type I, tumor necrosis factor-alpha receptor
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.